AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Top 1%
#39 out of 5150 analysts
Average Return
+95.51%
Win Rate
58%43 out of 74
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abivax SaABVX
+1,867.79%$6.38$125.55
2025-01-09 -
2025-12-12
Buy
Cidara Therapeutics IncCDTX
+1,084.38%$18.63$220.65
2025-05-08 -
2025-12-12
Buy
Cidara Therapeutics IncCDTX
+944.74%$21.12$220.65
2025-04-28 -
2025-12-12
Buy
Cidara Therapeutics IncCDTX
+873.53%$22.67$220.65
2025-06-01 -
2025-12-12
Buy
Cidara Therapeutics IncCDTX
+859.35%$23.00$220.65
2025-03-11 -
2025-12-12
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cidara Therapeutics IncCDTX
8Buy$173.00-21.60%Maintains
2 months ago
Assembly Biosciences IncASMB
1Buy$38.00+5.26%Initiates Coverage On
3 months ago
Dynavax Technologies CorpDVAX
8Buy$32.00+196.30%Reiterates
4 months ago
Enanta Pharmaceuticals IncENTA
14Buy$25.00+69.72%Maintains
4 months ago
Polypid LtdPYPD
2Buy$14.00+257.14%Maintains
6 months ago
Curevac NvCVAC
9Buy$10.00+98.02%Reiterates
7 months ago
An2 Therapeutics IncANTX
8Buy$2.00+66.67%Maintains
7 months ago
Inovio Pharmaceuticals IncINO
3Buy$18.00+773.79%Reiterates
9 months ago
Esperion Therapeutics IncESPR
3Buy$4.00+3.90%Reiterates
10 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$14.00+291.06%Maintains
10 months ago
Abivax SaABVX
1Buy$33.00-73.71%Reiterates
a year ago
Hookipa Pharma IncHOOK
2Buy$7.00N/AMaintains
a year ago
Gritstone Bio IncGRTSQ
4Buy$5.00N/AReiterates
a year ago
Arbutus Biopharma CorpABUS
5Buy$5.00N/AMaintains
a year ago
Pardes Biosciences IncPRDS
2Buy$5.00N/AMaintains
3 years ago
Argenx SeARGX
2Buy$448.00N/AMaintains
3 years ago
Cormedix IncCRMD
1Hold$16.00N/AMaintains
3 years ago
Ibio IncIBIO
1Buy$750.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.